Our results suggest that UTF1 promoter methylation profile could be used as a biomarker for cervical cancer diagnosis and raise the questions about the mechanisms involved in the regulation of its expression in epithelial tumors. The gene discussed is UTF1; the disease is cervical carcinoma.